Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Left Main Coronary Artery Disease: The OPTIVUS-Complex PCI Study LMCA Cohort.

IF 2.1 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Ryusuke Nishikawa, Hiroki Shiomi, Ko Yamamoto, Takeshi Morimoto, Akiyoshi Miyazawa, Kenji Ando, Takenori Domei, Toru Naganuma, Satoru Suwa, Kazushige Kadota, Yuko Onishi, Koh Ono, Koichi Kishi, Kohei Yoneda, Hideki Okayama, Kensho Matsuda, Takanari Fujita, Shojiro Tatsushima, Hiroki Sakamoto, Yukihiro Hamaguchi, Tairo Kurita, Akihiro Takasaki, Masami Nishino, Naotaka Okamoto, Hidekuni Kirigaya, Ren Kawaguchi, Jun Kuribara, Junichi Yamaguchi, Hiroyuki Arashi, Kiyoshi Hibi, Takeshi Kimura
{"title":"Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Left Main Coronary Artery Disease: The OPTIVUS-Complex PCI Study LMCA Cohort.","authors":"Ryusuke Nishikawa, Hiroki Shiomi, Ko Yamamoto, Takeshi Morimoto, Akiyoshi Miyazawa, Kenji Ando, Takenori Domei, Toru Naganuma, Satoru Suwa, Kazushige Kadota, Yuko Onishi, Koh Ono, Koichi Kishi, Kohei Yoneda, Hideki Okayama, Kensho Matsuda, Takanari Fujita, Shojiro Tatsushima, Hiroki Sakamoto, Yukihiro Hamaguchi, Tairo Kurita, Akihiro Takasaki, Masami Nishino, Naotaka Okamoto, Hidekuni Kirigaya, Ren Kawaguchi, Jun Kuribara, Junichi Yamaguchi, Hiroyuki Arashi, Kiyoshi Hibi, Takeshi Kimura","doi":"10.1016/j.amjcard.2025.09.018","DOIUrl":null,"url":null,"abstract":"<p><p>The impact of optimal intravascular ultrasound (IVUS)-guided left main coronary artery (LMCA) percutaneous coronary intervention (PCI) on clinical outcomes has not been adequately evaluated yet. The OPTIVUS-Complex PCI study LMCA cohort was a prospective multicenter single-arm trial enrolling 902 patients undergoing LMCA PCI targeting the prespecified IVUS criteria (minimal stent area ≥5.0 mm<sup>2</sup> for left circumflex artery ostium, ≥6 mm<sup>2</sup> for left anterior descending coronary artery ostium, ≥7 mm<sup>2</sup> for polygon of confluence, and ≥8.0 mm<sup>2</sup> for proximal LMCA). The primary endpoint was a composite of death, myocardial infarction, stroke, or any coronary revascularization. The predefined performance goals were based on the CREDO-Kyoto PCI/coronary artery bypass grafting (CABG) registry cohort-2 (PCI: 32.0%, and CABG: 13.9%). The OPTIVUS criteria were met in 73.7% of patients. The prevalence of true bifurcation LMCA lesion was 18.4%. The cumulative 1-year incidence of the primary endpoint was 13.2% (95%CI: 11.0-15.4%), which was significantly lower than the PCI performance goal (32.0%, P<0.0001), and numerically lower than the CABG performance goal (13.9%). The cumulative 1-year incidences of target-lesion revascularization and target-lesion revascularization for LMCA lesions were 4.2% and 3.0%. The cumulative 1-year incidence of the primary endpoint was not different regardless of meeting or not meeting the OPTIVUS criteria (13.4% versus 14.2%, log-rank P=0.79), while those of target-lesion revascularization and target-lesion revascularization for LMCA lesions were significantly lower in patients meeting the OPTIVUS criteria than in patients not meeting the OPTIVUS criteria (3.3% versus 7.7%, log-rank P=0.01, and 2.3% versus 5.5%, log-rank P=0.02). In conclusion, IVUS-guided LMCA PCI targeting the OPTIVUS criteria in the contemporary clinical practice was associated with a significantly lower rate of cardiovascular event than the predefined PCI performance goal, and with a numerically lower rate of cardiovascular event than the predefined CABG performance goal at 1 year.</p>","PeriodicalId":7705,"journal":{"name":"American Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjcard.2025.09.018","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

The impact of optimal intravascular ultrasound (IVUS)-guided left main coronary artery (LMCA) percutaneous coronary intervention (PCI) on clinical outcomes has not been adequately evaluated yet. The OPTIVUS-Complex PCI study LMCA cohort was a prospective multicenter single-arm trial enrolling 902 patients undergoing LMCA PCI targeting the prespecified IVUS criteria (minimal stent area ≥5.0 mm2 for left circumflex artery ostium, ≥6 mm2 for left anterior descending coronary artery ostium, ≥7 mm2 for polygon of confluence, and ≥8.0 mm2 for proximal LMCA). The primary endpoint was a composite of death, myocardial infarction, stroke, or any coronary revascularization. The predefined performance goals were based on the CREDO-Kyoto PCI/coronary artery bypass grafting (CABG) registry cohort-2 (PCI: 32.0%, and CABG: 13.9%). The OPTIVUS criteria were met in 73.7% of patients. The prevalence of true bifurcation LMCA lesion was 18.4%. The cumulative 1-year incidence of the primary endpoint was 13.2% (95%CI: 11.0-15.4%), which was significantly lower than the PCI performance goal (32.0%, P<0.0001), and numerically lower than the CABG performance goal (13.9%). The cumulative 1-year incidences of target-lesion revascularization and target-lesion revascularization for LMCA lesions were 4.2% and 3.0%. The cumulative 1-year incidence of the primary endpoint was not different regardless of meeting or not meeting the OPTIVUS criteria (13.4% versus 14.2%, log-rank P=0.79), while those of target-lesion revascularization and target-lesion revascularization for LMCA lesions were significantly lower in patients meeting the OPTIVUS criteria than in patients not meeting the OPTIVUS criteria (3.3% versus 7.7%, log-rank P=0.01, and 2.3% versus 5.5%, log-rank P=0.02). In conclusion, IVUS-guided LMCA PCI targeting the OPTIVUS criteria in the contemporary clinical practice was associated with a significantly lower rate of cardiovascular event than the predefined PCI performance goal, and with a numerically lower rate of cardiovascular event than the predefined CABG performance goal at 1 year.

超声引导下经皮冠状动脉介入治疗左主干疾病的最佳方法:OPTIVUS-Complex PCI研究LMCA队列
最佳血管内超声(IVUS)引导下左主干冠状动脉(LMCA)经皮冠状动脉介入治疗(PCI)对临床预后的影响尚未得到充分评价。OPTIVUS-Complex PCI研究LMCA队列是一项前瞻性多中心单臂试验,纳入902名接受LMCA PCI治疗的患者,目标是预先指定的IVUS标准(左旋动脉口最小支架面积≥5.0 mm2,左冠状动脉前降支口≥6 mm2,合流形≥7 mm2, LMCA近端≥8.0 mm2)。主要终点是死亡、心肌梗死、中风或任何冠状动脉血运重建术的复合终点。预定义的性能目标是基于CREDO-Kyoto PCI/冠状动脉旁路移植术(CABG)注册队列2 (PCI: 32.0%, CABG: 13.9%)。73.7%的患者符合OPTIVUS标准。LMCA真分叉病变发生率为18.4%。主要终点累积1年发生率为13.2% (95%CI: 11.0-15.4%),显著低于PCI性能目标(32.0%,P
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Cardiology
American Journal of Cardiology 医学-心血管系统
CiteScore
4.00
自引率
3.60%
发文量
698
审稿时长
33 days
期刊介绍: Published 24 times a year, The American Journal of Cardiology® is an independent journal designed for cardiovascular disease specialists and internists with a subspecialty in cardiology throughout the world. AJC is an independent, scientific, peer-reviewed journal of original articles that focus on the practical, clinical approach to the diagnosis and treatment of cardiovascular disease. AJC has one of the fastest acceptance to publication times in Cardiology. Features report on systemic hypertension, methodology, drugs, pacing, arrhythmia, preventive cardiology, congestive heart failure, valvular heart disease, congenital heart disease, and cardiomyopathy. Also included are editorials, readers'' comments, and symposia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信